Stock Events

Stock Events

Heron Therapeutics 

$0.3042
74
-$0.02-4.95% 15:19 Today

Statistics

Day High
0.3152
Day Low
0.301
52W High
1.58
52W Low
0.3
Volume
1,127,256
Avg. Volume
3,479,951
Mkt Cap
57.74M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.1
-0.06
-0.02
0.02
Expected EPS
-0.025
Actual EPS
N/A

Financials

-13.04%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
154.9MRevenue
-20.2MNet Income

Analyst Ratings

0.00Average Price Target
The highest estimate is 0.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
0%
Hold
100%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HRTX. It's not an investment recommendation.
Microsoft
14
MSFT
Amazon
13
AMZN
NVIDIA
13
NVDA
Tesla
12
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pacira BioSciences
PCRX
Mkt Cap916.82M
Pacira Biosciences specializes in non-opioid pain management, directly competing with Heron's post-operative pain solutions.
Alkermes
ALKS
Mkt Cap8.23B
Alkermes competes in the broader pharmaceuticals market, including treatments for conditions that Heron targets.
Amphastar Pharmaceuticals
AMPH
Mkt Cap889.47M
Amphastar Pharmaceuticals produces drugs that can be used in similar applications as Heron's, such as acute pain management.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.85B
Teva Pharmaceutical Industries offers a wide range of generic and specialty medicines, including those that compete in Heron's therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its pharmaceutical division Janssen, develops drugs that compete across several of Heron's key areas, including pain management.
Merck
MRK
Mkt Cap335.14B
Merck & Co. operates in various therapeutic areas, including those where Heron is trying to make a mark, making them a broad competitor.
Pfizer
PFE
Mkt Cap152.69B
Pfizer competes across a wide range of therapeutic areas, including those relevant to Heron's portfolio, such as pain management.
Novartis
NVS
Mkt Cap286.78B
Novartis offers a broad portfolio that includes treatments in areas competing with Heron, such as analgesics and supportive care medications.

About

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Show more...
CEO
Craig Alexander Collard
Employees
128
Country
United States
ISIN
US4277461020
WKN
000A1XB6K

Listings

F
DE
AXD2.F
STU
DE
AXD2.STU
MU
DE
AXD2.MU
XNAS
US
HRTX

0 Comments

Share your thoughts

FAQ

What is Heron Therapeutics stock price today?▼
The current price of HRTX is $0.30 USD — it has decreased by -4.95% in the past 24 hours. Watch Heron Therapeutics stock price performance more closely on the chart.
What is Heron Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Heron Therapeutics stocks are traded under the ticker HRTX.
Is Heron Therapeutics stock price growing?▼
HRTX stock has fallen by -6.11% compared to the previous week, the month change is a -35.42% fall, over the last year Heron Therapeutics has showed a -76.62% decrease.
What is Heron Therapeutics market cap?▼
Today Heron Therapeutics has the market capitalization of 57.74M
When is the next Heron Therapeutics earnings date?▼
Heron Therapeutics is going to release the next earnings report on November 10, 2026.
What were Heron Therapeutics earnings last quarter?▼
HRTX earnings for the last quarter are -0.03 USD per share, whereas the estimation was -0.01 USD resulting in a -500% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Heron Therapeutics revenue for the last year?▼
Heron Therapeutics revenue for the last year amounts to 154.9M USD.
What is Heron Therapeutics net income for the last year?▼
HRTX net income for the last year is -20.2M USD.
How many employees does Heron Therapeutics have?▼
As of August 18, 2026, the company has 128 employees.
In which sector is Heron Therapeutics located?▼
Heron Therapeutics operates in the Health & Wellness sector.
When did Heron Therapeutics complete a stock split?▼
The last stock split for Heron Therapeutics was on January 13, 2014 with a ratio of 1:20.
Where is Heron Therapeutics headquartered?▼
Heron Therapeutics is headquartered in SAN DIEGO, United States.